Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
91 participants
OBSERVATIONAL
2021-12-01
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Every children with elevated serum lipase after trauma during those years will be selected.
The children with pancreatic tumors will be excluded. American Association of Surgeon Trauma (AAST) classification of pancreas injury will be used to grade severity.
Children will be divided in two groups : one including pancreatic lesion with duct injury and one without duct injury.
Data will include mechanism of injury, associated injury, length of stay, maximal lipase level, nutritional care and local complications will be noted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score
NCT03456557
Are the Pancreatic Serum Proteins Pancreatic Stone Protein (PSP) and Pancreatitis-Associated Protein (PAP) Predictive for the Development of Sepsis? Retrospective Study in Trauma Patients With Soft Tissue Defects.
NCT00564109
Establishment and Verification of Pancreatic Volume Formula Based on Imaging
NCT05410795
Post-ERCP Pancreatitis Severity Indication (PEPSI) Study
NCT03075592
Soluble Triggering Receptor Expressed on Myeloid Cells in Severe Acute Pancreatitis
NCT01193413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Every children with elevated serum lipase
Every children with elevated serum lipase after trauma during those years will be included.
data collection
data collection : mechanism of injury, associated injury, length of stay, maximal lipase level, nutritional care and local complications.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
data collection : mechanism of injury, associated injury, length of stay, maximal lipase level, nutritional care and local complications.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aurélien SCALABRE, MD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN472021/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.